• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Annual screening for ovarian cancer does not significantly reduce mortality

bySuchita Nety
July 18, 2021
in StudyGraphics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Both CA125 serum and transvaginal ultrasound annual screening did not significantly reduce deaths due to ovarian or tubal cancer compared to no annual screening.

2. The incidence of stage III-IV disease was decreased in the CA125 screening group compared to no annual screening.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Ovarian cancer has a 5-year survival rate of greater than 90% if diagnosed at stage I. However, most diagnoses occur once the cancer has already metastasized and 5-year survival rates drop below 15%. Different annual screening tools, such as transvaginal ultrasounds (USS) and serum CA125 measurements (MMS), have been developed in hopes of increasing cancer detection. However, this randomized control trial of over 200 000 women in the UK did not find a significant reduction in mortality with annual MMS or USS screening compared to no screening. Interestingly, MMS increased detection of stage I disease compared to no screening, but this was not adequate to reduce mortality rates. While these results may indicate no benefit of annual screening in the general population, they have limited applicability to women at high-risk for ovarian cancer. Nonetheless, this study’s biggest strength was its large size and long follow-up period (16.3 years). While these results do not support the recommendation of annual ovarian cancer screening, more info is needed on the cost-effectiveness and feasibility of these screening methods to truly determine potential benefit in a clinical setting.

Click to read the study in the Lancet

Relevant Reading: Effect of Screening on Ovarian Cancer Mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial

In-Depth [randomized controlled trial]: This randomized control trial was a continuation of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), which recruited women aged 50-74 years between 2001 to 2005. 202 562 women were included in the final intention-to-treat analysis. Women were assigned randomly in a 1:1:2 ratio to an MMS, USS, and no screening group. The primary outcome recorded was death due to ovarian or tubal cancer by the study end-date of June 30th, 2020. The mean follow-up time was 16.3 years. The MMS group had a higher incidence of stage I and II cancer detected compared to the no screening group, as well as a lower incidence of stage III and IV cancer. Between groups, the incidence of ovarian or tubal cancer was similar with 1% of patients in each receiving a diagnosis (MMS, 522 of 50 625; USS, 517 of 50 623); no screening, 1016 of 101 314). In total, there were 1206 deaths reported, with an equal percentage of women (0.6%) in each group being affected.

RELATED REPORTS

Increases in muscle-strengthening activities may reduce mortality risk and certain diseases

COVID-19 pandemic associated with reductions in delivery of cancer care services in Ontario, Canada

Wellness Check: Exercise

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: CA125cancer screeningmortalityovarianovarian cancerscreeningtransvaginal ultrasoundtubal cancer
Previous Post

External validation shows Epic Sepsis Model is a poor predictor of sepsis in hospitalized patients

Next Post

Informal social gatherings such as birthdays associated with increased rates of COVID-19 infection

RelatedReports

Exercise improves aromatase inhibitor-induced arthralgia in breast cancer survivors
Cardiology

Increases in muscle-strengthening activities may reduce mortality risk and certain diseases

May 3, 2022
Chronic Disease

COVID-19 pandemic associated with reductions in delivery of cancer care services in Ontario, Canada

April 29, 2022
Few older adolescents meet recommended levels of physical activity
Wellness

Wellness Check: Exercise

April 28, 2022
Wellness

Higher religious adherence may be associated with lower mortality

March 29, 2022
Next Post
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Informal social gatherings such as birthdays associated with increased rates of COVID-19 infection

Real-time continuous glucose monitoring improves glycemic control compared to intermittently scanned monitoring for patients with type 1 diabetes

#VisualAbstract: Annual screening for ovarian cancer does not significantly reduce mortality

#VisualAbstract: Upadacitinib plus topical corticosteroids is safe and effective for moderate-to-severe atopic dermatitis;

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Wellness Check: Mental Health
  • #VisualAbstract: Addition of elotuzumab to lenalidomide and dexamethasone did not significantly improve survival outcomes in newly diagnosed, transplant-ineligible multiple myeloma
  • #VisualAbstract: Pretreatment with radiotherapy and two cycles of concurrent cisplatin may reduce toxicity in locally advanced nasopharyngeal carcinoma
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.